Journal of Cancer Research and Clinical Oncology

Article	Citations
Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients	162
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	134
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	100
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	93
A case of rare metachronous four primary carcinoma	82
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	71
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	69
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	65
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	61
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	58
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	57
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	53
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	50
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	50
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	49
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany	49
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	48
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	46
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	46
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy	43
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	43
Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry	41
Safety and efficacy of tomosynthesis-guided breast biopsies in the prone position: monocentric study and review of the literature	41
Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence	39
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	39

Can whole-body MRI replace CT in management of metastatic testicular cancer? A prospective, non-inferiority study	39
Expression and clinical prognostic value of CYB561 in breast cancer	38
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	37
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	36
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	33
Comparison of cisplatin and mitomycin C/5-FU as radiosensitisers in the treatment of locally advanced vulvar cancer: results of a retrospective, observational, single-institutional cohort study	31
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	31
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors	31
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	30
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)	29
Correction to: The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo	29
Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma	29
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	28
Expression of estrogen-related receptors in ovarian cancer and impact on survival	28
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	28
Claudins as biomarkers of differential diagnosis and prognosis of tumors	28
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma	27
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study	27
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas	27
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	27
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy	27
Comparison of three different methods to detect bone marrow involvement in patients with neuroblastoma	27
Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo	26
Targeting tumor vascularization: promising strategies for vascular normalization	26
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	26
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	26
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	26
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells	26
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	26
Systematic analysis of mistletoe prescriptions in clinical studies	24
Precision medicine for cancer patients: worth a special issue	24
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis	24
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	24
Breast cancer prediction using different machine learning methods applying multi factors	24
Comparison of intracorporeal and extracorporeal anastomosis in left hemicolectomy: updated meta-analysis of retrospective control trials	23
Characterization of tumor microenvironment infiltration and therapeutic responses of cell cycle-related genes’ signature in breast cancer	23
Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction	23
Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial	23
BTB protein family and human breast cancer: signaling pathways and clinical progress	23
The different clonal origins of metachronous and synchronous metastases	23
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives	22
Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study	22
Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinoma	22
Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany	22
Reversing resistance to immune checkpoint inhibitor by adding recombinant human adenovirus type 5 in a patient with small cell lung cancer with promoted immune infiltration: a case report	22
Single-cell transcriptome highlights a multilayer regulatory network on an invasive trajectory within colorectal cancer progression	22
Decreased expression of prolyl hydroxylase 1 is associated with poor prognosis in colorectal cancers	21
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology g	21
Incidence profile of four major cancers among migrants in Australia, 2005–2014	21
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized	21

Noninvasive grading of glioma brain tumors using magnetic resonance imaging and deep learning methods	21
The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations	21
Emerging markers of cancer cachexia and their relationship to sarcopenia	21
Significance of spread through air spaces in small cell lung cancer	21
Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment	21
Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study	20
Global research trends in tumor stem cell-derived exosomes and tumor microenvironment: visualization biology analysis	20
DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer	20
Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma	20
Development and external validation of a clinical–radiomics nomogram for preoperative prediction of LVSI status in patients with endometrial carcinoma	20
Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma	20
Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines	19
Frailty assessment tools predict perioperative outcome in elderly patients with endometrial cancer better than age or BMI alone: a retrospective observational cohort study	19
Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen	19
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro	19
Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer	19
Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial	18
95% Confidence intervals or P-values?	18
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients	18
Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world	18
What do hematologists and oncologists consider necessary for their career? Results of an online survey in Germany, Austria and Switzerland	18
MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety	18
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practice	18
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials	18
Construction and validation of a nomogram for hepatocellular carcinoma patients treated by traditional Chinese medicine based on inflammation, nutrition, and blood lipid indicators	18
A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations	18
Clinical research progress on BRAF V600E-mutant advanced colorectal cancer	18
D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma	18
“I do not hear you!”: hearing-impaired cancer patients report their communication experiences	18
Quality of life in Tunisian colorectal cancer patients: a cross-sectional study	18
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma	18
Graph neural network-based breast cancer diagnosis using ultrasound images with optimized graph construction integrating the medically significant features	18
HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer	18
Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma	18
Effect of mindfulness yoga on anxiety and depression in early breast cancer patients received adjuvant chemotherapy: a randomized clinical trial	17
Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC	17
Real world data on IO-based therapy for metastatic renal cell carcinoma	17
A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors	17
Automatic breast cancer diagnosis based on hybrid dimensionality reduction technique and ensemble classification	17
NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis	17
METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b	17
Water therapies (hydrotherapy, balneotherapy or aqua therapy) for patients with cancer: a systematic review	17
Establishing a metastasis-related diagnosis and prognosis model for lung adenocarcinoma through CRISPR library and TCGA database	17
Efficacy of CDK4/6 inhibitors combined with endocrine therapy in HR+/HER2− breast cancer: an umbrella review	17
Two novel clinical tools to predict the risk of bone metastasis and overall survival in esophageal cancer patients: a large population-based retrospective cohort study	17
Association of birth weight with cancer risk: a dose–response meta-analysis and Mendelian randomization study	17
GUEST EDITORIAL: Theranostics in breast cancer—a vision	17
Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer	17
Secular trends and attributable risk factors of esophageal cancer deaths among non-elderly adults based on Global Burden of Disease Study	17
Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion	16
Clinical applications of minimally invasive uniportal video-assisted thoracic surgery	16
The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer	16
Primary retroperitoneal squamous cell carcinoma: a literature review	16
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients	16
Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects	16
Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany	16
Prognostic value of preoperative microscopic hematuria in patients with non-metastatic renal cell carcinoma who underwent nephrectomy	16
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence	16
Predictive biomarkers for immunotherapy response in extensive-stage SCLC	16
A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer	16
Efficacy of rechallenge immunotherapy after immune monotherapy resistance in patients with advanced non-small cell lung cancer	16
Developing prognostic nomograms to predict overall survival and cancer-specific survival in synchronous multiple primary colorectal cancer based on the SEER database	16
Investigation of the roles of IL-18 (-607 C/A) and IL-18 (-137 G/C) gene variations in bladder cancer development: case–control study	15
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up	15
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer	15
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia	15
Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease	15
Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy	15
Nurses’ knowledge of chemotherapy-induced neutropenia and its management: a cross-sectional survey	15
Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey	15
Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer	15
TKIs beyond immunotherapy predict improved survival in advanced HCC	15
Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation	15
Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms	14
PARP inhibitors and overall survival in ovarian cancer, reevaluation advised in all settings	14
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo-)radiotherapy: a systematic review and meta-analysis	14
Are sleep disorders associated with the risk of gastrointestinal cancer?—A case–control study	14
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing	14
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage	14
Novel scoring system guiding the incorporation of adjuvant RT for neuroendocrine neoplasms treated with surgical resection followed by chemotherapy	14

The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis	14
The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer	14
Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study	14
Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer	14
Prognostic modelling of colorectal cancer based on oxidative stress-related genes	14
Clinical characteristics and prognosis of patients with co-existing follicular lymphoma and diffuse large B-cell lymphoma components in rituximab era	14
SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer	14
Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients	14
Differential diagnosis of lymphoma with 18F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy	14
Association between secondhand smoke and cancers in adults in the US population	14
The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib	14
The HDAC inhibitor domatinostat induces type I interferon α in Merkel cell carcinoma by HES1 repression	13
The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular ca	13
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study	13
Breast cancer knowledge and practices amongst women in Algeria	13
Feasibility study on individualized management of postoperative patients with differentiated thyroid cancer based on internet and programming technology	13
Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?	13
Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options	13
Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis	13
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis	13
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system	13
Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors	13
Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes	13
Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds	13
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif® in healthy Chinese subjects	13
Advances in the application of computational pathology in diagnosis, immunomicroenvironment recognition, and immunotherapy evaluation of breast cancer: a narrative review	13
Brown fat activation demonstrated on FDG PET/CT predicts survival outcome	13
Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC	13
Oral cancer awareness campaign in Northern Germany: successful steps to raise awareness for early detection	13
Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer	12
Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases	12
Identification and validation of a plasma metabolomics-based model for risk stratification of intrahepatic cholangiocarcinoma	12
Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms	12
Hematopoietic stem cell transplantation for acute lymphoblastic leukemia: why do adolescents and young adults outcomes differ from those of children? A retrospective study on behalf of the Francophone	12
Brain metastases of sarcoma: a rare phenomenon in rare tumours	12
Response to letter to the editor regarding C Franzese et al. “Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer”	12
Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study	12
Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules	12
Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia	12
Outcomes of immunotherapy-related hepatotoxicity from a multi-disciplinary toxicity team	12
Current trends of targeted therapy for oral squamous cell carcinoma	12
Hepatic artery intervention combined with immune-targeted therapy is superior to sequential therapy in BCLC-C hepatocellular carcinoma	12
Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review	12
Effect of segmental versus marginal mandibular resection on local and lymph node recurrences in oral squamous cell carcinoma: is tumorous bone infiltration or location and resulting soft tissue recurr	12
Comparing strategy of immune checkpoint inhibitors plus chemotherapy with chemotherapy alone for small cell lung cancer: a meta-analysis based on six RCTs incorporating 2800 participants	12
An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma	12
Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with PTEN loss and increased risk of biochemical recurrence in a cohort of middle eastern men with pros	12
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA	12
KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target	12
Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis	12
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers	12
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments	12
Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images	12
LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway	12
Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus	12
Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study	12
A novel postoperative nomogram and risk classification system for individualized estimation of survival among patients with parotid gland carcinoma after surgery	12
Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure	12
Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy	12
Interactions of occult tumor spread and surgical technique on overall and disease-free survival in patients operated for stage I and II right-sided colon cancer	12
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract	12
Intratumoral delivery of a Tim-3 antibody-encoding oncolytic adenovirus engages an effective antitumor immune response in liver cancer	12
Developing an effective quality evaluation strategy of next-generation sequencing for accurate detecting non-small cell lung cancer samples with variable characteristics: a real-world clinical practic	12
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma	12
MicroRNA expression associated with low-grade cervical intraepithelial neoplasia outcomes	11
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement	11
The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia	11
AHR, a novel inhibitory immune checkpoint receptor, is a potential therapeutic target for chemoresistant glioblastoma	11
ShallowHRD status acts as an effective prognostic predictor in ovarian cancer patients treated by poly (ADP-ribose) polymerase inhibitors (PARPis)	11
Herpes zoster is not associated with subsequent gastrointestinal cancer: data from over 200,000 outpatients in Germany	11
Correlation of several forms of folic acid with endometrial cancer: cross-sectional data from the National Health and Nutrition Examination Surveys (NHANES) 2011–2018	11
Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma	11
A competing risk nomogram to predict cancer-specific mortality of patients with late-onset colorectal cancer	11
Targeting adipocyte–immune cell crosstalk to control breast cancer progression	11
Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma	11
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center	11
Early clinical trial unit tumor board: a real-world experience in a national cancer network	11
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese S	11
Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer	11
Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes	11
Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity	11
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate	11
Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment	11
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns	11
Causal relationship between lung diseases and risk of esophageal cancer: insights from Mendelian randomization	11
Commentary on: Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis	11
Expression profiling of luminal B breast tumor in Indian women	11
Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients	11
What would one of the greatest natural scientists and educators of the eighteenth century, Georg Christoph Lichtenberg, say about the current therapy management of patients with penile cancer?	11
The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis	11
Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer	11
Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma	11
The value of an apparent diffusion coefficient histogram model in predicting meningioma recurrence	11
Classification of the immune microenvironment associated with 12 cell death modes and construction of a prognostic model for squamous cell lung cancer	11
Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules	11